Cytokinetics Inc CYTK:NASDAQ

Last Price$43.55Cboe Real-Time Last Sale as of 12:17PM ET 7/06/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.35(0.80%)
Bid (Size)$43.38 (31)
Ask (Size)$43.68 (100)
Day Low / High$43.00 - 45.50
Volume725.7 K
  • Latest Stories
  • Commentary and Analysis
Sector Update: Health Care Stocks Mixed Premarket Friday
9:14AM ET 7/01/2022 MT Newswires

Health care stocks were mixed premarket Friday. The Health Care SPDR (XLV) was 0.28% lower, and the iShares NASDAQ Biotechnology Index (IBB) was recently...

Cytokinetics Prices $450 Million Private Placement of Convertible Notes; Doubles Development Loan
4:00AM ET 7/01/2022 MT Newswires

Cytokinetics (CYTK) said Friday it has priced a private placement of $450 million principal amount of 3.5% convertible senior notes due 2027. Initial...

Sector Update: Health Care Stocks Swoon Late, Closing Lower
4:06PM ET 6/30/2022 MT Newswires

Health care stocks slipped fully below the surface this afternoon, with the NYSE Health Care Index falling 0.2% and the SPDR Health Care Select Sector ETF...

Sector Update: Health Care Stocks Little Changed on Thursday
1:59PM ET 6/30/2022 MT Newswires

Health care stocks were narrowly mixed this afternoon, with the NYSE Health Care Index sliding 0.1% while the SPDR Health Care Select Sector ETF (XLV) was...

Update: Cytokinetics Proposes Private Offering of $450 Million Convertible Senior Notes -- Shares Sink in Pre-Market Trading
7:06AM ET 6/30/2022 MT Newswires

(Updates with the stock move in the headline and the first paragraph.) Cytokinetics (CYTK) shares slumped more than 17% in the most recent pre-market...

Update: Cytokinetics Proposes Private Offering of $450 Million Convertible Senior Notes -- Shares Sink in Late Hours
5:22PM ET 6/29/2022 MT Newswires

(Updates with the stock move in the headline and first paragraph.) Cytokinetics (CYTK) shares slumped more than 14% in late-hours trading after the company...

Cytokinetics Proposes Private Offering of $450 Million Convertible Senior Notes
4:46PM ET 6/29/2022 MT Newswires

Cytokinetics (CYTK) said Wednesday it proposed a private offering of $450 million of convertible senior notes due 2027. The company expects to grant the...

Cytokinetics Says FDA Advisory Committee to Meet in December to Review NDA for Heart Disease Drug
8:08AM ET 6/24/2022 MT Newswires

Cytokinetics (CYTK) said Friday the US Food and Drug Administration's cardiovascular and renal drugs advisory committee will meet on Dec. 13 to review its...

Insider Sell: Cytokinetics
4:31PM ET 6/17/2022 MT Newswires

Robert I Blum, Director, President & CEO, on June 15, 2022, sold 10,000 shares in Cytokinetics (CYTK) for $394,000. Following the Form 4 filing with the...

Cytokinetics Says Prescription Drug User Fee Act Date for Heart Failure Treatment Application Extended by Three Months
9:29AM ET 6/17/2022 MT Newswires

Cytokinetics (CYTK) said Friday the US Food and Drug Administration has extended the Prescription Drug User Fee Act date for the company's new drug...